Abbott Laboratories (NYSE:ABT) received approval from the FDA for its rapid antigen test. The test which allegedly can detect whether a patient has COVID-19 in under 15 minutes.
According to healthcare professionals the “$5 rapid test” could be the game changer in testing protocols for the virus.
As there is an increasing perception that the Coronavirus is less of a threat with new testing methods like this one and possible vaccinations developing… how will the market react to short-term COVID headlines and where will the broader markets trend towards?
Well, Abbott’s stock was up 8% on the back of the news as of writing this and transports such as airlines and cruise-liners were starting to catch a bid.
Watch the full interview to see which stocks Lance Ippolito is trading to make money today…